The impact of primary prophylaxis for cryptococcosis on fluconazole resistance in Candida species.
Apisarnthanarak
Anucha
A
Mundy
Linda M
LM
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D002175:Candida / Q000187:drug effects*; D003453:Cryptococcosis / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control*; D025141:Drug Resistance, Fungal; D015725:Fluconazole / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D006801:Humans
D015725:Fluconazole